Company: DMAAR
Filing Date: 2025-05-20
Form Type: 10-Q
Source: 0001213900-25-046061
Chunk: 84

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-05-20
Form: 10-Q
Item: Part I, Item 8
Chunk 84
---
8614

    2025-05-20

    0002028614

    2025-03-31

    0002028614

    2024-12-31

    0002028614
    
      us-gaap:RelatedPartyMember

    2025-03-31

    0002028614
    
      us-gaap:RelatedPartyMember

    2024-12-31

    0002028614
    
      dmaau:RedeemableOrdinaryShareMember

    2025-01-01
    2025-03-31

    0002028614
    
      dmaau:NonRedeemableOrdinaryShareMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:CommonStockMember

    2024-12-31

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2024-12-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2024-12-31

    0002028614
    
      us-gaap:RetainedEarningsMember

    2024-12-31

    0002028614
    
      us-gaap:CommonStockMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:RetainedEarningsMember

    2025-01-01
    2025-03-31

    0002028614
    
      us-gaap:CommonStockMember

    2025-03-31

    0002028614
    
      us-gaap:ReceivablesFromStockholderMember

    2025-03-31

    0002028614
    
      us-gaap:AdditionalPaidInCapitalMember